Injectable contraception in shock link to increased risk of brain tumour
An injectable contraception used by some women in the UK has been linked to an increased risk of a type of brain tumour.
A study, published in the British Medical Journal (BMJ), found people using injectable medroxyprogesterone acetate for more than a year appear to have a higher risk of meningioma – a tumour of the membranes covering the brain and spinal cord.
It is usually benign but can cause
